Psychosocial – GeneLit

Cancer screening and breast cancer family history in Spanish-speaking Hispanic/Latina women in California.
Tamayo LI, Perez F, Perez A, Hernandez M, Martinez A, Huang X, Zavala V, Ziv E, Neuhausen S, Carvajal-Carmona LG, Duron Y, Fejerman L.
Front Oncol. 2022 Sep 28;12:940162. doi: 10.3389/fonc.2022.940162.

Comparison of psychological distress for breast, ovarian and colorectal cancer predisposition in a Spanish sample at high risk of hereditary cancer.
Costa-Requena G, Garcia-Garijo M, Richart-Aznar P, Segura-Huerta Á.
Eur J Cancer Prev. 2022 Sep 1;31(5):482-486. doi: 10.1097/CEJ.0000000000000734. Epub 2021 Dec 15.

Returning individual genomic results to population-based cohort study participants with BRCA1/2 pathogenic variants.
Ohneda K, Hamanaka Y, Kawame H, Fuse N, Nagami F, Suzuki Y, Yamaguchi-Kabata Y, Shimada M, Masamune A, Aoki Y, Ishida T, Yamamoto M.
Breast Cancer. 2022 Sep 26. doi: 10.1007/s12282-022-01404-7. Epub ahead of print.

Perspectives on Spanish language concordant cancer genetic counseling sessions from the Spanish-speaking population.
Jimenez S, Matthews A, Darrah R, Schreiber A, Ricker C, Wolfe Schneider K.
J Genet Couns. 2022 Sep 19. doi: 10.1002/jgc4.1628. Epub ahead of print.

Resilience as a Source of Easement to Health-Related Worries in Women at Increased Risk for Breast or Ovarian Cancer During the COVID-19 Pandemic.
Schwab R, Droste A, Stewen K, Elger T, Theis S, Heimes AS, Peters K, Schmidt M, Brenner W, Hasenburg A.
Int J Gen Med. 2022 Sep 5;15:7039-7052. doi: 10.2147/IJGM.S373191.

Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing.
Bokkers K, Bleiker EMA, Hoogendam JP, Velthuizen ME, Schreuder HWR, Gerestein CG, Lange JG, Louwers JA, Koudijs MJ, Ausems MGEM, Zweemer RP.
Hered Cancer Clin Pract. 2022 Sep 8;20(1):33. doi: 10.1186/s13053-022-00238-w.

Risk-reducing mastectomy for unaffected women with a strong family history of breast cancer.
Willson ML, Srinivasa S, Fatema K, Lostumbo L, Carbine NE, Egger SJ, Goodwin A.
Cochrane Database Syst Rev. 2022 Sep 6;9(9):CD015020. doi: 10.1002/14651858.CD015020.pub2.

An accessible, relational, inclusive, and actionable (ARIA) model of genetic counseling compared with usual care: Results of a randomized controlled trial.
Joseph G, Leo MC, Riddle L, Guerra C, Amendola LM, Gilmore MJ, Rolf BA, Dorschner MO. Zepp J, Biesecker BB, Caruncho M. Hunter JEKeast E, Lewis HS, Duenas D, Kauffman T, Bulkley JE, Anderson KP, Jarvik GP, Goddard KAB, Wilfond BS, on behalf of theCHARM Study Team.
Genet Med. 2022 Sep 1:S1098-3600(22)00876-0. doi: 10.1016/j.gim.2022.07.025. Epub ahead of print.

Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants.
Liu YL, Maio A, Kemel Y, Salo-Mullen EE, Sheehan M, Tejada PR, Trottier M, Arnold AG, Fleischut MH, Latham A, Carlo MI, Murciano-Goroff YR, Walsh MF, Mandelker D, Mehta N, Bandlamudi C, Arora K, Zehir A, Berger MF, Solit DB, Aghajanian C, Diaz LA Jr, Robson ME, Brown CL, Offit K, Hamilton JG, Stadler ZK.
Cancer. 2022 Aug 30. doi: 10.1002/cncr.34434. Epub ahead of print.